Apollo Hospitals Enterprise Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹6,606Cr
- +18.1% YoY
- +2% QoQ
- Net profit
- ₹551Cr
- +33.1% YoY
- +6.8% QoQ
- Margin
- 15%
- +1 pp YoY
- 0 pp QoQ
Guidance rank: #6 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
What the Q4 FY26 call signalled
3 of 3 strong
The short version
Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
From Apollo Hospitals Enterprise Ltd's Q4 FY26 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth.
- 30% growth currently driven by top 5 markets; expansion planned into new markets.
- Pharmacy business acquiring 200,000-220,000 new customers monthly, expected to increase with 7,500 outlets synergy.
- Diagnostics business growing 25%-30%, with plans to further grow and strengthen through integration.
- Hospital services targeting mid-teen revenue growth in FY27; expecting gradual revenue acceleration and better asset utilization.
- New hospitals adding about 1,400 beds, with phased commissioning; 500-600 beds expected operational by mid-FY27.
2 more points from Apollo Hospitals Enterprise Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
- INR 1,980 crore capex is planned for FY27 to commission 1,000 new beds.
- Four new hospitals operationalized in FY26 with 855 beds capacity; 185 beds operationalized, remaining 670 beds to be commissioned over next 12 months.
- Two more hospitals (Sarjapur and Gurugram) expected to be commissioned in the next two quarters, adding up to approximately 1,400 beds in metro markets by FY28.
- Investments ongoing in clinical leadership (oncology, robotics, advanced care), technology, and digital health to improve consumer engagement and operational integration.
2 more points from Apollo Hospitals Enterprise Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Apollo Hospitals Enterprise Ltd said on order book & pipeline — free account, 30 seconds.
Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit
Apollo Hospitals Enterprise Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 6,606 | 5,592 | +18.1% | 6,477 | +2% |
| Operating profit (EBITDA) | 1,011 | 770 | +31.3% | 965 | +4.8% |
| Operating margin | 15% | 14% | +1 pp | 15% | 0 pp |
| Profit before tax | 722 | 516 | +39.9% | 682 | +5.9% |
| Net profit (PAT) | 551 | 414 | +33.1% | 516 | +6.8% |
| EPS (₹) | 36.81 | 27.10 | +35.8% | 34.93 | +5.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹7.6K Cr, net profit ₹660 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Apollo Hospitals's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Apollo Hospitals Enterprise Ltd Q4 FY26 results?
Apollo HealthCo aims for INR 25,000 crore revenue run rate by Q4 FY27, growing from INR 19,000 crore pro forma basis in FY26, targeting 21% growth. Company expects overall Healthcare Services to deliver mid-teen revenue growth in FY27 with improved margins by at least 100 bps in established units.
What is Apollo Hospitals Enterprise Ltd share price analysis?
Apollo Hospitals Enterprise Ltd currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 59.4 with a market cap of ₹124,992 Cr. Investors should review the full earnings analysis for detailed insights.
Is Apollo Hospitals Enterprise Ltd planning capital expenditure?
Growth capex for hospitals is expected to continue at around INR 550 crore annually, considered fully redeployable for expansion.
Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
